Format
Sort by
Items per page

Send to

Choose Destination

Best matches for CAV1 and Breast Neoplasms:

Search results

Items: 1 to 20 of 124

1.

Signaling pathway of globo-series glycosphingolipids and β1,3-galactosyltransferase V (β3GalT5) in breast cancer.

Chuang PK, Hsiao M, Hsu TL, Chang CF, Wu CY, Chen BR, Huang HW, Liao KS, Chen CC, Chen CL, Yang SM, Kuo CW, Chen P, Chiu PT, Chen IJ, Lai JS, Yu CT, Wong CH.

Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3518-3523. doi: 10.1073/pnas.1816946116. Epub 2019 Feb 11.

PMID:
30808745
2.

CAV1 polymorphisms rs1049334, rs1049337, rs7804372 might be the potential risk in tumorigenicity of urinary cancer: A systematic review and meta-analysis.

Fan S, Meng J, Zhang L, Zhang X, Liang C.

Pathol Res Pract. 2019 Jan;215(1):151-158. doi: 10.1016/j.prp.2018.11.009. Epub 2018 Nov 13.

PMID:
30463805
3.

Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines.

Campos A, Salomon C, Bustos R, Díaz J, Martínez S, Silva V, Reyes C, Díaz-Valdivia N, Varas-Godoy M, Lobos-González L, Quest AF.

Nanomedicine (Lond). 2018 Oct;13(20):2597-2609. doi: 10.2217/nnm-2018-0094. Epub 2018 Oct 19.

PMID:
30338706
4.

Caveolin‑1 enhances RANKL‑induced gastric cancer cell migration.

Wang Y, Song Y, Che X, Zhang L, Wang Q, Zhang X, Qu J, Li Z, Xu L, Zhang Y, Fan Y, Hou K, Liu Y, Qu X.

Oncol Rep. 2018 Sep;40(3):1287-1296. doi: 10.3892/or.2018.6550. Epub 2018 Jul 5.

5.

Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer.

Monti D, Sotgia F, Whitaker-Menezes D, Tuluc M, Birbe R, Berger A, Lazar M, Cotzia P, Draganova-Tacheva R, Lin Z, Domingo-Vidal M, Newberg A, Lisanti MP, Martinez-Outschoorn U.

Semin Oncol. 2017 Jun;44(3):226-232. doi: 10.1053/j.seminoncol.2017.10.001. Epub 2017 Oct 10.

6.

Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis.

Celus W, Di Conza G, Oliveira AI, Ehling M, Costa BM, Wenes M, Mazzone M.

Cell Rep. 2017 Dec 5;21(10):2842-2854. doi: 10.1016/j.celrep.2017.11.034.

7.

Hedgehog-mesenchyme gene signature identifies bi-modal prognosis in luminal and basal breast cancer sub-types.

Torres-García W, Domenech M.

Mol Biosyst. 2017 Nov 21;13(12):2615-2624. doi: 10.1039/c7mb00416h.

8.

Bisphenol A induces proliferative effects on both breast cancer cells and vascular endothelial cells through a shared GPER-dependent pathway in hypoxia.

Xu F, Wang X, Wu N, He S, Yi W, Xiang S, Zhang P, Xie X, Ying C.

Environ Pollut. 2017 Dec;231(Pt 2):1609-1620. doi: 10.1016/j.envpol.2017.09.069. Epub 2017 Sep 28.

PMID:
28964603
9.

Caveolae-Mediated Endocytosis Is Critical for Albumin Cellular Uptake and Response to Albumin-Bound Chemotherapy.

Chatterjee M, Ben-Josef E, Robb R, Vedaie M, Seum S, Thirumoorthy K, Palanichamy K, Harbrecht M, Chakravarti A, Williams TM.

Cancer Res. 2017 Nov 1;77(21):5925-5937. doi: 10.1158/0008-5472.CAN-17-0604. Epub 2017 Sep 18.

10.

The diversity in the expression profile of caveolin II transcripts, considering its new transcript in breast cancer.

Ariana M, Arabi N, Pornour M, Vaseghi H, Ganji SM, Alivand MR, Salari M, Akbari ME.

J Cell Biochem. 2018 Feb;119(2):2168-2178. doi: 10.1002/jcb.26378. Epub 2017 Oct 30.

PMID:
28857238
11.

Caveolin-1 expression as a prognostic marker in triple negative breast cancers of Asian women.

Yeong J, Thike AA, Ikeda M, Lim JCT, Lee B, Nakamura S, Iqbal J, Tan PH.

J Clin Pathol. 2018 Feb;71(2):161-167. doi: 10.1136/jclinpath-2017-204495. Epub 2017 Jul 22.

PMID:
28735300
12.
13.

HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity.

Zhang C, Xu B, Lu S, Zhao Y, Liu P.

Mol Cancer. 2017 May 11;16(1):90. doi: 10.1186/s12943-017-0656-1.

14.

Altering calcium influx for selective destruction of breast tumor.

Yu HG, McLaughlin S, Newman M, Brundage K, Ammer A, Martin K, Coad J.

BMC Cancer. 2017 Mar 4;17(1):169. doi: 10.1186/s12885-017-3168-x.

15.

Expression of Stromal Caveolin- 1 May Be a Predictor for Aggressive Behaviour of Breast Cancer.

Eliyatkin N, Aktas S, Diniz G, Ozgur HH, Ekin ZY, Kupelioglu A.

Pathol Oncol Res. 2018 Jan;24(1):59-65. doi: 10.1007/s12253-017-0212-8. Epub 2017 Feb 24.

PMID:
28236153
16.

Integrated analysis of gene expression and methylation profiles of 48 candidate genes in breast cancer patients.

Li Z, Heng J, Yan J, Guo X, Tang L, Chen M, Peng L, Wu Y, Wang S, Xiao Z, Deng Z, Dai L, Wang J.

Breast Cancer Res Treat. 2016 Nov;160(2):371-383. Epub 2016 Oct 8.

PMID:
27722841
17.

Ultrasound-targeted microbubble destruction of calcium channel subunit α 1D siRNA inhibits breast cancer via G protein-coupled receptor 30.

Ji Y, Han Z, Shao L, Zhao Y.

Oncol Rep. 2016 Oct;36(4):1886-92. doi: 10.3892/or.2016.5031. Epub 2016 Aug 23.

18.

Coexpression of CAV-1, AT1-R and FOXM1 in prostate and breast cancer and normal cell lines and their influence on metastatic properties.

Kowalska K, Nowakowska M, Domińska K, Piastowska-Ciesielska AW.

Acta Biochim Pol. 2016;63(3):493-9. doi: 10.18388/abp.2015_1016. Epub 2016 May 20.

19.

Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo.

Yang H, Guan L, Li S, Jiang Y, Xiong N, Li L, Wu C, Zeng H, Liu Y.

Oncotarget. 2016 Mar 29;7(13):16227-47. doi: 10.18632/oncotarget.7583. Erratum in: Oncotarget. 2018 Aug 24;9(66):32730.

20.

Modulation of 17β-Estradiol Signaling on Cellular Proliferation by Caveolin-2.

Totta P, Gionfra F, Busonero C, Acconcia F.

J Cell Physiol. 2016 Jun;231(6):1219-25. doi: 10.1002/jcp.25218. Epub 2015 Oct 23.

PMID:
26480297

Supplemental Content

Loading ...
Support Center